EFL1 mutations impair eIF6 release to cause Shwachman-Diamond syndrome.


Journal

Blood
ISSN: 1528-0020
Titre abrégé: Blood
Pays: United States
ID NLM: 7603509

Informations de publication

Date de publication:
18 07 2019
Historique:
received: 21 12 2018
accepted: 10 05 2019
pubmed: 4 6 2019
medline: 15 1 2020
entrez: 2 6 2019
Statut: ppublish

Résumé

Shwachman-Diamond syndrome (SDS) is a recessive disorder typified by bone marrow failure and predisposition to hematological malignancies. SDS is predominantly caused by deficiency of the allosteric regulator Shwachman-Bodian-Diamond syndrome that cooperates with elongation factor-like GTPase 1 (EFL1) to catalyze release of the ribosome antiassociation factor eIF6 and activate translation. Here, we report biallelic mutations in EFL1 in 3 unrelated individuals with clinical features of SDS. Cellular defects in these individuals include impaired ribosomal subunit joining and attenuated global protein translation as a consequence of defective eIF6 eviction. In mice, Efl1 deficiency recapitulates key aspects of the SDS phenotype. By identifying biallelic

Identifiants

pubmed: 31151987
pii: S0006-4971(20)42400-0
doi: 10.1182/blood.2018893404
pmc: PMC6754720
doi:

Substances chimiques

EFL1 protein, human 0
Peptide Elongation Factors 0
Peptide Initiation Factors 0
Ribonucleoprotein, U5 Small Nuclear 0
eIF-6 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

277-290

Subventions

Organisme : Medical Research Council
ID : MC_PC_12009
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UP_A390_1106
Pays : United Kingdom
Organisme : Medical Research Council
ID : 1330931
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L003368/1
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_U105161083
Pays : United Kingdom

Informations de copyright

© 2019 by The American Society of Hematology.

Références

Haematologica. 2012 Sep;97(9):1312-9
pubmed: 22491737
Ann N Y Acad Sci. 2011 Dec;1242:40-55
pubmed: 22191555
J Cell Biol. 2006 May 8;173(3):349-60
pubmed: 16651379
Nature. 2003 Dec 4;426(6966):579-84
pubmed: 14654845
Nature. 2015 Apr 30;520(7549):640-5
pubmed: 25901680
Blood. 2011 Oct 20;118(16):4305-12
pubmed: 21803848
Rare Dis. 2015 Apr 01;3(1):e1025185
pubmed: 26442198
Blood. 2018 Sep 20;132(12):1318-1331
pubmed: 29914977
RNA. 2007 Sep;13(9):1570-81
pubmed: 17652132
Proc Natl Acad Sci U S A. 2012 Jan 10;109(2):413-8
pubmed: 22160674
Nat Rev Genet. 2007 Oct;8(10):762-75
pubmed: 17846636
Front Bioeng Biotechnol. 2015 Jan 26;3:8
pubmed: 25674564
Nat Commun. 2016 Aug 18;7:12444
pubmed: 27534441
N Engl J Med. 2017 Feb 9;376(6):536-547
pubmed: 28177873
J Med Genet. 2017 Aug;54(8):558-566
pubmed: 28331068
Science. 2011 Nov 18;334(6058):941-8
pubmed: 22052974
Br J Haematol. 2012 May;157(4):503-5
pubmed: 22295858
Nat Rev Genet. 2006 Jul;7(7):552-64
pubmed: 16770338
J Cell Biol. 2012 Jun 11;197(6):747-59
pubmed: 22689654
Blood. 2017 Mar 16;129(11):1557-1562
pubmed: 28062395
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Cell Stem Cell. 2007 Oct 11;1(4):428-42
pubmed: 18371379
Nat Genet. 2003 Jan;33(1):97-101
pubmed: 12496757
Child Neuropsychol. 2005 Oct;11(5):471-5
pubmed: 16306021
Genes Dev. 2011 May 1;25(9):917-29
pubmed: 21536732
Nature. 2014 May 1;509(7498):49-54
pubmed: 24670665
Cold Spring Harb Mol Case Stud. 2018 Oct 1;4(5):
pubmed: 29970384
J Biol Chem. 2010 Jan 8;285(2):961-8
pubmed: 19901025
Am J Hum Genet. 2016 Jul 7;99(1):115-24
pubmed: 27346687
Mol Cell. 2001 Dec;8(6):1363-73
pubmed: 11779510
J Biol Chem. 2008 Jan 4;283(1):231-6
pubmed: 17962198
Curr Opin Struct Biol. 2014 Feb;24:165-9
pubmed: 24524803
Clin Genet. 2018 Aug;94(2):252-258
pubmed: 29700810
Hum Mol Genet. 2009 Oct 1;18(19):3684-95
pubmed: 19602484
Blood. 2018 Feb 15;131(7):717-732
pubmed: 29146883
J Biol Chem. 2010 May 14;285(20):14848-51
pubmed: 20356839
Clin Genet. 2011 May;79(5):448-58
pubmed: 20569259
Nat Genet. 2014 Mar;46(3):310-5
pubmed: 24487276
J Clin Invest. 2017 Nov 1;127(11):4090-4103
pubmed: 28972538
Nat Methods. 2010 Apr;7(4):248-9
pubmed: 20354512
Br J Haematol. 2017 Nov;179(4):557-574
pubmed: 28875503
PLoS Genet. 2015 Jun 09;11(6):e1005288
pubmed: 26057580
PLoS Genet. 2017 Jan 5;13(1):e1006552
pubmed: 28056084
Blood. 2014 Oct 30;124(18):2784-92
pubmed: 25237201
Nucleic Acids Res. 2016 May 19;44(9):4134-46
pubmed: 26762974
Nat Genet. 2007 Apr;39(4):486-95
pubmed: 17353896
Mol Cell Biol. 2006 May;26(10):3718-27
pubmed: 16648468
Mol Cytogenet. 2013 Dec 12;6(1):56
pubmed: 24330778
Nat Struct Mol Biol. 2015 Nov;22(11):914-9
pubmed: 26479198
Proc Natl Acad Sci U S A. 2007 Jan 30;104(5):1558-63
pubmed: 17242366
Nat Protoc. 2009;4(7):1073-81
pubmed: 19561590

Auteurs

Shengjiang Tan (S)

Cambridge Institute for Medical Research, Cambridge, United Kingdom.
Department of Haematology, University of Cambridge, Cambridge, United Kingdom.
Wellcome Trust-Medical Research Council Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.

Laëtitia Kermasson (L)

INSERM Unité Mixte de Recherche 1163, Laboratory of Genome Dynamics in the Immune System, Equipe Labellisée Ligue contre le cancer, Paris, France.
Paris Descartes-Sorbonne Paris Cité University, Imagine Institute, Paris, France.

Angela Hoslin (A)

Medical Research Council Mammalian Genetics Unit, Harwell, United Kingdom.

Pekka Jaako (P)

Cambridge Institute for Medical Research, Cambridge, United Kingdom.
Department of Haematology, University of Cambridge, Cambridge, United Kingdom.
Wellcome Trust-Medical Research Council Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.

Alexandre Faille (A)

Cambridge Institute for Medical Research, Cambridge, United Kingdom.
Department of Haematology, University of Cambridge, Cambridge, United Kingdom.
Wellcome Trust-Medical Research Council Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.

Abraham Acevedo-Arozena (A)

Medical Research Council Mammalian Genetics Unit, Harwell, United Kingdom.
Unidad de Investigación, Hospital Universitario de Canarias, La Laguna, Spain.
Instituto de Tecnologías Biomédicas, Universidad de La Laguna, La Laguna, Spain.
Centro Investigación Biomédica en Red Enfermedades Neurodegenerativas, La Laguna, Spain.

Etienne Lengline (E)

Department of Hematology, CRNMR Aplasie Médullaire, Saint-Louis University Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.

Dana Ranta (D)

Department of Haematology, Centre Hospitalier Universitaire de Nancy, Nancy, France.

Maryline Poirée (M)

Department of Pediatric Hematology-Oncology, Centre Hospitalier Universitaire Lenval, Nice, France.

Odile Fenneteau (O)

Assistance Publique-Hôpitaux de Paris, Laboratory of Hematology, Robert Debré University Hospital, Paris, France.

Hubert Ducou le Pointe (H)

Radiology Department, Armand Trousseau Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
Department of Pediatric Imaging, Armand Trousseau Hospital, Sorbonne Universités, Pierre et Marie Curie-Paris University, Paris, France.

Stefano Fumagalli (S)

Institut Necker Enfants Malades, Paris, France.
INSERM, U1151, Université Paris Descartes Sorbonne Cité, Paris, France.

Blandine Beaupain (B)

French Neutropenia Registry, Assistance Publique-Hôpitaux de Paris, Trousseau Hospital, Paris, France.

Patrick Nitschké (P)

INSERM Unité Mixte de Recherche 1163, Bioinformatics Platform, Paris Descartes-Sorbonne Paris Cité University, Imagine Institute, Paris, France.

Christine Bôle-Feysot (C)

INSERM Unité Mixte de Recherche 1163, Genomics Platform, Paris Descartes-Sorbonne Paris Cité University, Imagine Institute, Paris, France.

Jean-Pierre de Villartay (JP)

INSERM Unité Mixte de Recherche 1163, Laboratory of Genome Dynamics in the Immune System, Equipe Labellisée Ligue contre le cancer, Paris, France.
Paris Descartes-Sorbonne Paris Cité University, Imagine Institute, Paris, France.

Christine Bellanné-Chantelot (C)

Department of Genetics, Hospital Pitié Salpétriére Assistance Publique-Hôpitaux de Paris, Sorbonne Université, Paris, France.

Jean Donadieu (J)

Service d'Hémato-Oncologie Pédiatrique, Assistance Publique-Hôpitaux de Paris Hôpital Trousseau, Registre des neutropénies-Centre de référence des neutropénies chroniques, Paris, France.

Caroline Kannengiesser (C)

Assistance Publique-Hôpitaux de Paris Service de Génétique, Hôpital Bichat, Paris, France; and.
Université Paris Diderot, Sorbonne Paris Cité, Paris, France.

Alan J Warren (AJ)

Cambridge Institute for Medical Research, Cambridge, United Kingdom.
Department of Haematology, University of Cambridge, Cambridge, United Kingdom.
Wellcome Trust-Medical Research Council Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.

Patrick Revy (P)

INSERM Unité Mixte de Recherche 1163, Laboratory of Genome Dynamics in the Immune System, Equipe Labellisée Ligue contre le cancer, Paris, France.
Paris Descartes-Sorbonne Paris Cité University, Imagine Institute, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH